We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Six Factors Shaping Successful Immunoassay Commercialization

3D render of antibodies binding target molecules in an immunoassay, producing a fluorescent detection signal.
Credit: iStock.

Immunoassay development is advancing rapidly, but strong analytical performance alone is not enough to ensure commercial success. 


In order to succeed, developers must balance clinical utility, regulatory requirements, manufacturing scalability, workflow integration, and post-launch lifecycle management. 


This listicle explores six critical factors that can help transform promising immunoassay technologies into products that meet the needs of laboratories, clinicians, and healthcare systems.


Download this listicle to learn: 

  • Why intended use should guide development from the start
  • How regulatory and manufacturing considerations influence commercialization
  • The role of user experience and post-market insights in supporting adoption
Download the List for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.